Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03715933
Title Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inhibrx, Inc.
Indications

gastric adenocarcinoma

malignant pleural mesothelioma

colorectal adenocarcinoma

sarcoma

Advanced Solid Tumor

Therapies

INBRX-109

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.